PT3388111T - Composto organoarsénico para o tratamento de cancro - Google Patents
Composto organoarsénico para o tratamento de cancroInfo
- Publication number
- PT3388111T PT3388111T PT181748179T PT18174817T PT3388111T PT 3388111 T PT3388111 T PT 3388111T PT 181748179 T PT181748179 T PT 181748179T PT 18174817 T PT18174817 T PT 18174817T PT 3388111 T PT3388111 T PT 3388111T
- Authority
- PT
- Portugal
- Prior art keywords
- cancer
- treatment
- organoarsenic compound
- organoarsenic
- compound
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/285—Arsenic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18951108P | 2008-08-20 | 2008-08-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3388111T true PT3388111T (pt) | 2021-12-23 |
Family
ID=41707414
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT181748179T PT3388111T (pt) | 2008-08-20 | 2009-08-14 | Composto organoarsénico para o tratamento de cancro |
| PT09808635T PT2321012T (pt) | 2008-08-20 | 2009-08-14 | Compostos organoarsénicos e métodos para o tratamento de cancro |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT09808635T PT2321012T (pt) | 2008-08-20 | 2009-08-14 | Compostos organoarsénicos e métodos para o tratamento de cancro |
Country Status (19)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016540775A (ja) * | 2013-12-05 | 2016-12-28 | ソレイジア・ファーマ株式会社 | 癌の処置のための化合物および方法 |
| CN104151397A (zh) * | 2014-07-03 | 2014-11-19 | 北京大学 | 一类新型三硫杂二环有机砷化物及其合成方法和在抗肿瘤领域里的应用 |
| JP6413969B2 (ja) * | 2015-07-29 | 2018-10-31 | 住友金属鉱山株式会社 | 日射遮蔽体形成用分散液および当該分散液を用いた日射遮蔽体 |
| JPWO2019220961A1 (ja) * | 2018-05-18 | 2020-05-28 | ソレイジア・ファーマ株式会社 | ダリナパルシンのアルカリ金属塩及び／又は無機酸付加塩の結晶型及びその製剤 |
| US11998654B2 (en) | 2018-07-12 | 2024-06-04 | Bard Shannon Limited | Securing implants and medical devices |
| CN113408945B (zh) * | 2021-07-15 | 2023-03-24 | 广西中烟工业有限责任公司 | 一种烤烟纯度的检测方法、装置、电子设备及存储介质 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US234972A (en) | 1880-11-30 | William ennis | ||
| US761900A (en) | 1904-03-05 | 1904-06-07 | Newton Jefferson Norman | Flux compound. |
| US2349729A (en) | 1940-08-24 | 1944-05-23 | Parke Davis & Co | Therapeutic arsenic preparation |
| PT2018858E (pt) | 1997-10-15 | 2011-03-24 | Polarx Biopharmaceuticals Inc | Composições e métodos para o tratamento de doenças neoplásicas primárias e metastáticas usando compostos de arsénio |
| ES2395515T3 (es) | 1997-11-10 | 2013-02-13 | Memorial Sloan Kettering Cancer Center | Trióxido de arsénico para uso en el tratamiento de la leucemia |
| CN1233476A (zh) | 1998-04-24 | 1999-11-03 | 陆道培 | 治疗急性白血病的药物及其制备方法 |
| EP1002537A1 (en) | 1998-10-30 | 2000-05-24 | Assistance Publique, Hopitaux De Paris | Use of melarsoprol for the manufacture of a medicament for treating B-cell lymphoproliferative diseases, such as multiple myeloma |
| US6191123B1 (en) | 1999-03-19 | 2001-02-20 | Parker Hughes Institute | Organic-arsenic compounds |
| IL152433A0 (en) | 2000-04-26 | 2003-05-29 | Univ Oregon Health Sciences | Administration of a thiol-based chemoprotectant compound |
| DE10132625A1 (de) | 2001-07-05 | 2003-01-23 | Oce Printing Systems Gmbh | Verfahren, Computerprogrammprodukt und Gerätesystem zum visuellen Überprüfen von Bilddaten |
| EP2462932A1 (en) * | 2002-01-07 | 2012-06-13 | Board Of Regents, The University Of Texas System | S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer |
| TW201440760A (zh) * | 2004-07-16 | 2014-11-01 | Texas A & M Univ Sys | 有機砷化合物、其用於治療癌症之用途及包含其之醫藥組成物 |
| WO2007027344A2 (en) * | 2005-07-29 | 2007-03-08 | Ziopharm Oncology, Inc. | Compounds and methods for the treatment of cancer |
| WO2007082104A2 (en) * | 2006-01-13 | 2007-07-19 | The Texas A & M University System | Compounds and methods for the treatment of cancer |
| TW200829261A (en) | 2006-09-29 | 2008-07-16 | Ziopharm Oncology Inc | Method for controlling angiogenesis in animals |
| AU2008276451A1 (en) * | 2007-07-17 | 2009-01-22 | Zalicus Inc. | Treatments of B-cell proliferative disorders |
| EP2178370A4 (en) * | 2007-07-17 | 2011-01-12 | Zalicus Inc | COMBINATIONS FOR THE TREATMENT OF PROLIFERATIVE B-CELL DISEASES |
| JP2011502985A (ja) * | 2007-11-02 | 2011-01-27 | ジオファーム オンコロジー， インコーポレイテッド | 有機ヒ素剤を使用する併用療法 |
| US20100009934A1 (en) * | 2008-06-09 | 2010-01-14 | Combinatorx, Incorporated | Beta adrenergic receptor agonists for the treatment of b-cell proliferative disorders |
-
2009
- 2009-08-14 ES ES18174817T patent/ES2901426T3/es active Active
- 2009-08-14 SG SG10201403869TA patent/SG10201403869TA/en unknown
- 2009-08-14 DK DK09808635.8T patent/DK2321012T3/en active
- 2009-08-14 AU AU2009282972A patent/AU2009282972A1/en not_active Abandoned
- 2009-08-14 CA CA2734650A patent/CA2734650A1/en not_active Abandoned
- 2009-08-14 SG SG10201810450QA patent/SG10201810450QA/en unknown
- 2009-08-14 RU RU2011110392/14A patent/RU2534606C2/ru active
- 2009-08-14 NZ NZ591181A patent/NZ591181A/xx not_active IP Right Cessation
- 2009-08-14 EP EP09808635.8A patent/EP2321012B1/en active Active
- 2009-08-14 KR KR1020187026317A patent/KR20180103194A/ko not_active Ceased
- 2009-08-14 MX MX2011001800A patent/MX2011001800A/es not_active Application Discontinuation
- 2009-08-14 ES ES09808635T patent/ES2703740T3/es active Active
- 2009-08-14 SG SG10201810449XA patent/SG10201810449XA/en unknown
- 2009-08-14 PT PT181748179T patent/PT3388111T/pt unknown
- 2009-08-14 US US13/059,176 patent/US20110269697A1/en not_active Abandoned
- 2009-08-14 EP EP18174817.9A patent/EP3388111B1/en active Active
- 2009-08-14 JP JP2011523888A patent/JP5933896B2/ja active Active
- 2009-08-14 CN CN2009801356542A patent/CN102149432A/zh active Pending
- 2009-08-14 KR KR1020117006250A patent/KR20110058818A/ko not_active Ceased
- 2009-08-14 DK DK18174817.9T patent/DK3388111T3/da active
- 2009-08-14 BR BRPI0918407A patent/BRPI0918407A2/pt not_active Application Discontinuation
- 2009-08-14 CN CN201410740427.5A patent/CN104800828A/zh active Pending
- 2009-08-14 PT PT09808635T patent/PT2321012T/pt unknown
- 2009-08-14 WO PCT/US2009/053858 patent/WO2010021928A1/en not_active Ceased
- 2009-08-14 KR KR1020177024240A patent/KR20170103023A/ko not_active Ceased
-
2011
- 2011-02-10 IL IL211153A patent/IL211153A0/en unknown
- 2011-02-15 ZA ZA2011/01216A patent/ZA201101216B/en unknown
-
2014
- 2014-05-26 JP JP2014108079A patent/JP5976036B2/ja active Active
- 2014-10-27 US US14/524,586 patent/US10842769B2/en active Active
-
2015
- 2015-03-30 JP JP2015068284A patent/JP2015120755A/ja not_active Withdrawn
-
2016
- 2016-01-07 HK HK16100117.0A patent/HK1212218A1/xx unknown
- 2016-09-29 JP JP2016191062A patent/JP6315841B2/ja active Active
-
2017
- 2017-12-19 JP JP2017242759A patent/JP2018039853A/ja active Pending
-
2020
- 2020-10-15 US US17/071,435 patent/US11324713B2/en active Active
- 2020-10-15 US US17/071,623 patent/US11324714B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LT2303021T (lt) | Junginiai, skirti vėžio gydymui | |
| PT3517534T (pt) | Compostos uteis para o tratamento de cancro | |
| ZA201105720B (en) | Compounds for the treatment of hepatitis c | |
| IL215772A0 (en) | Composition for the treatment of prostate cancer | |
| IL213398A0 (en) | Compounds for treating cancer | |
| IL213761A0 (en) | Novel ortho-aminoamides for the treatment of cancer | |
| ZA201003425B (en) | 5-cyano-thienopyridines for the treatment of tumors | |
| GB0804496D0 (en) | Treating cancer | |
| PT3388111T (pt) | Composto organoarsénico para o tratamento de cancro | |
| IL210066A0 (en) | Novel ortho-aminoanilides for the treatment of cancer | |
| ZA201001546B (en) | Isoxazole compounds for the treatment of cancer | |
| GB0707556D0 (en) | Treatment for cancer | |
| AP2011005893A0 (en) | Thia-triaza-cyclopentazulenes as P13-kinases inhibitors for the treatment of cancer. | |
| GB0809046D0 (en) | Cancer treatment | |
| GB0604114D0 (en) | Combinations for the treatment of cancer | |
| GB0814469D0 (en) | Treatment for tumours | |
| GB0914322D0 (en) | Compounds for treating cancer | |
| HK1162949A (zh) | 治療癌症的組合療法 | |
| AU2007906570A0 (en) | Compounds for treating cancer | |
| GB0819536D0 (en) | Compounds for the treatment of neoplasia | |
| GB0817857D0 (en) | Compounds for the treatment of neoplasia | |
| HK1169987A (en) | Compound suitable for the treatment of synucleopathies |